Prevalence of bacterial contamination in 50% dextrose vials in varying storage conditions after multiple punctures. 2018

K A Marshall, and A C Brooks, and G K Hammac, and E J Thomovsky, and P A Johnson
Departments of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN 47909, USA.

OBJECTIVE To determine the risk of bacterial growth in single use 50% dextrose vials punctured multiple times and stored in various hospital environments. METHODS Three groups of three 50% dextrose vials were stored in our hospital intensive care unit at either ambient light or in a darkened drawer at room temperature or refrigerated at 4°C. One vial in each group was punctured either once, once weekly or once daily for 28 days and samples taken for bacterial culture every 7 days until completion of the project. A fourth group of three vials were inoculated with several species of bacteria and stored in our microbiology laboratory under the environmental conditions described above with cultures performed every 7 days for 28 days. In addition, the water activity of 50% dextrose was determined using commercial laboratory equipment. RESULTS Scant growth of Escherichia coli and Enterobacter agglomerans was detected in cultures performed on day 7, but not subsequent time points, from the inoculated refrigerated vials. The vial punctured once daily for 28 days and stored under refrigerated conditions showed growth of Bacillus subtilis on day 28. All remaining bottles had no bacterial growth at any time point or environmental condition. The water activity of 50% dextrose was 093 at 24°C and 092 at 4°C. CONCLUSIONS Bacterial growth in 50% dextrose vials was uncommon even when inoculated with pathogens. Bacterial growth only occurred in refrigerated storage conditions. The water activity of 50% dextrose is not low enough to inhibit all bacterial and fungal growth.

UI MeSH Term Description Entries
D012034 Refrigeration The mechanical process of cooling. Cold Chain,Chain, Cold,Chains, Cold,Cold Chains
D004340 Drug Contamination The presence of organisms, or any foreign material that makes a drug preparation impure. Drug Adulteration,Drug Contamination, Chemical,Drug Contamination, Microbial,Drug Contamination, Physical,Drug Impurity,Adulteration, Drug,Chemical Drug Contamination,Chemical Drug Contaminations,Contamination, Chemical Drug,Contamination, Drug,Contamination, Microbial Drug,Contamination, Physical Drug,Contaminations, Chemical Drug,Contaminations, Microbial Drug,Contaminations, Physical Drug,Drug Adulterations,Drug Contaminations,Drug Contaminations, Chemical,Drug Contaminations, Microbial,Drug Contaminations, Physical,Drug Impurities,Impurity, Drug,Microbial Drug Contamination,Microbial Drug Contaminations,Physical Drug Contamination,Physical Drug Contaminations
D004356 Drug Storage The process of keeping pharmaceutical products in an appropriate location. Drug Storages,Storage, Drug,Storages, Drug
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006762 Hospitals, Animal Facility for in-house medical care of animals. Animal Hospitals,Hospitals, Veterinary,Veterinary Clinics,Veterinary Hospitals,Clinics, Veterinary,Animal Hospital,Clinic, Veterinary,Hospital, Animal,Hospital, Veterinary,Veterinary Clinic,Veterinary Hospital
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013696 Temperature The property of objects that determines the direction of heat flow when they are placed in direct thermal contact. The temperature is the energy of microscopic motions (vibrational and translational) of the particles of atoms. Temperatures
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014867 Water A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Hydrogen Oxide

Related Publications

K A Marshall, and A C Brooks, and G K Hammac, and E J Thomovsky, and P A Johnson
February 2004, American journal of infection control,
K A Marshall, and A C Brooks, and G K Hammac, and E J Thomovsky, and P A Johnson
July 2013, Journal of diabetes science and technology,
K A Marshall, and A C Brooks, and G K Hammac, and E J Thomovsky, and P A Johnson
March 1993, The Annals of pharmacotherapy,
K A Marshall, and A C Brooks, and G K Hammac, and E J Thomovsky, and P A Johnson
January 2007, Wiener medizinische Wochenschrift (1946),
K A Marshall, and A C Brooks, and G K Hammac, and E J Thomovsky, and P A Johnson
April 1969, Anesthesiology,
K A Marshall, and A C Brooks, and G K Hammac, and E J Thomovsky, and P A Johnson
January 2013, Iranian journal of pharmaceutical research : IJPR,
K A Marshall, and A C Brooks, and G K Hammac, and E J Thomovsky, and P A Johnson
May 1973, AORN journal,
K A Marshall, and A C Brooks, and G K Hammac, and E J Thomovsky, and P A Johnson
November 1968, Journal of the South Carolina Medical Association (1975),
K A Marshall, and A C Brooks, and G K Hammac, and E J Thomovsky, and P A Johnson
October 1953, Nordisk medicin,
K A Marshall, and A C Brooks, and G K Hammac, and E J Thomovsky, and P A Johnson
October 1975, American journal of hospital pharmacy,
Copied contents to your clipboard!